Methyldopa hydrate
Methyldopa hydrate is an antihypertensive agent that acts as a DOPA decarboxylase inhibitor and an indirect α2-adrenergic agonist. It reduces sympathetic outflow and catecholamine synthesis, and its NO-dependent sedative properties have been investigated in both in vivo and in vitro models of hypertension research.
Product Specifications
CAS Number
41372-08-1
Product Name Alternative
Prodrug, response, α-Methyldopa Sesquihydrate, DOPA decarboxylase, DopamineReceptor, Dopamine Receptor, antihyoertensive, a-Methyldopa Sesquihydrate, Adrenergic Receptor, AdrenergicReceptor, MK351, MK-351, MK351 Hydrate, L-α-Methyldopa Hydrate, MK 351, MK 351 Hydrate, Methyldopa, metabolized, hyperglycemic, L-alpha-Methyldopa Hydrate, L-a-Methyldopa Hydrate
Field of Research
Metabolism Research, Neuroscience, Pharmacology & Drug Discovery
Purity
≥98% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (8.39 mM) ; DMSO:12 mg/mL (50.37 mM)
Smiles
O.C[C@] (N) (Cc1ccc (O) c (O) c1) C (O) =O
Molecular Formula
C10H13NO4·3/2H2O
Molecular Weight
238.24
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog